Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunochemotherapy: Do Platin-based Chemotherapeutics Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients?

NCT02285413 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02285413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunochemotherapy: Do Platin-based Chemotherapeutics Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients?
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
April 30, 2016
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma